Final results from GCIG/ENGOT/AGO-OVAR 12, a randomised placebo-controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer. - Ray-Coquard I; Cibula D; Mirza MR; Reuss A; Ricci C; Colombo N; Koch H; Goffin F; González-Martin A; Ottevanger PB; Baumann K; Bjørge L; et al. (International journal of cancer, 2020)